- Home
- SSSS vs BDTX Comparison
SSSS vs BDTX Comparison
Compare SSSS & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSSS
- BDTX
- Stock Information
- Founded
- SSSS 2010
- BDTX 2014
- Country
- SSSS United States
- BDTX United States
- Employees
- SSSS N/A
- BDTX 54
- Industry
- SSSS Finance: Consumer Services
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSSS Finance
- BDTX Health Care
- Exchange
- SSSS Nasdaq
- BDTX Nasdaq
- Market Cap
- SSSS 143.5M
- BDTX 126.8M
- IPO Year
- SSSS N/A
- BDTX 2020
- Fundamental
- Price
- SSSS $6.31
- BDTX $2.34
- Analyst Decision
- SSSS Buy
- BDTX Strong Buy
- Analyst Count
- SSSS 2
- BDTX 4
- Target Price
- SSSS $7.00
- BDTX $15.50
- AVG Volume (30 Days)
- SSSS 195.3K
- BDTX 1.2M
- Earning Date
- SSSS 03-12-2025
- BDTX 03-11-2025
- Dividend Yield
- SSSS N/A
- BDTX N/A
- EPS Growth
- SSSS N/A
- BDTX N/A
- EPS
- SSSS N/A
- BDTX N/A
- Revenue
- SSSS $5,903,895.00
- BDTX N/A
- Revenue This Year
- SSSS N/A
- BDTX N/A
- Revenue Next Year
- SSSS N/A
- BDTX N/A
- P/E Ratio
- SSSS N/A
- BDTX N/A
- Revenue Growth
- SSSS 5.43
- BDTX N/A
- 52 Week Low
- SSSS $3.32
- BDTX $1.91
- 52 Week High
- SSSS $6.74
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- SSSS 59.47
- BDTX 51.35
- Support Level
- SSSS $6.21
- BDTX $2.10
- Resistance Level
- SSSS $6.74
- BDTX $2.33
- Average True Range (ATR)
- SSSS 0.28
- BDTX 0.17
- MACD
- SSSS 0.04
- BDTX 0.04
- Stochastic Oscillator
- SSSS 61.74
- BDTX 52.63
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.